339 related articles for article (PubMed ID: 17721999)
1. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.
Merritt MA; Green AC; Nagle CM; Webb PM; ;
Int J Cancer; 2008 Jan; 122(1):170-6. PubMed ID: 17721999
[TBL] [Abstract][Full Text] [Related]
2. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
Mills PK; Riordan DG; Cress RD; Young HA
Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
4. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
8. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
[TBL] [Abstract][Full Text] [Related]
9. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
10. [Endometriosis as a risk factor for ovarian cancer].
Vargas-Hernández VM
Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
[TBL] [Abstract][Full Text] [Related]
11. Alcohol consumption and ovarian cancer risk in a population-based case-control study.
Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Hampton JM; Willett WC; Egan KM
Int J Cancer; 2006 Nov; 119(10):2423-7. PubMed ID: 16921486
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for different histological types of ovarian cancer.
Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C
Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
[TBL] [Abstract][Full Text] [Related]
16. Population attributable fractions for ovarian cancer in Swedish women by morphological type.
Granström C; Sundquist J; Hemminki K
Br J Cancer; 2008 Jan; 98(1):199-205. PubMed ID: 18071361
[TBL] [Abstract][Full Text] [Related]
17. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Penninkilampi R; Eslick GD
Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.
Murphy MA; Trabert B; Yang HP; Park Y; Brinton LA; Hartge P; Sherman ME; Hollenbeck A; Wentzensen N
Cancer Causes Control; 2012 Nov; 23(11):1839-52. PubMed ID: 22972000
[TBL] [Abstract][Full Text] [Related]
19. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
Rasmussen CB; Faber MT; Jensen A; Høgdall E; Høgdall C; Blaakær J; Kjaer SK
Cancer Causes Control; 2013 Jul; 24(7):1459-64. PubMed ID: 23615817
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for ovarian cancer histotypes.
Chiaffarino F; Parazzini F; Bosetti C; Franceschi S; Talamini R; Canzonieri V; Montella M; Ramazzotti V; Franceschi S; La Vecchia C
Eur J Cancer; 2007 May; 43(7):1208-13. PubMed ID: 17376671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
